12 completed, 1 terminated. 8 Phase 1, 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 7, Terminated 1 |
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow ASP2151: new trials by email Literature Review of ASP2151 trials Research Report on ASP2151
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug-Drug Interaction Study: ASP2151 and Midazolam Midazolam, ASP2151 - Healthy | Phase 1 | Completed | Maruho Europe Limited | 27 | 2015-04-01 | 2019-02-21 |
| Drug-Drug Interaction Study: ASP2151 and Bupropion Bupropion, ASP2151 - Healthy | Phase 1 | Completed | Maruho Europe Limited | 24 | 2015-02-01 | 2019-02-21 |
| Drug-Drug Interaction Study: ASP2151 and Montelukast Montelukast, ASP2151 - Healthy | Phase 1 | Completed | Maruho Europe Limited | 24 | 2014-12-01 | 2019-02-27 |
| Drug-Drug Interaction Study: ASP2151 and Ciclosporin ASP2151 400mg + 100mg ciclosporin, ASP2151 1200mg + 100mg ciclosporin - Healthy | Phase 1 | Completed | Maruho Europe Limited | 26 | 2014-10-01 | 2019-05-03 |
| Drug-Drug Interaction Study: ASP2151 and Ritonavir ASP2151, ritonavir - Healthy | Phase 1 | Completed | Maruho Europe Limited | 48 | 2014-09-01 | 2019-02-27 |
| Open-label Study of ASP2151 in Herpes Simplex Patients ASP2151 - Herpes Simplex | Phase 3 | Completed | Maruho Co., Ltd. | 275 | 2013-11-01 | 2024-09-27 |
| Phase III Study of ASP2151 in Herpes Zoster Patients ASP2151, valaciclovir - Herpes Zoster | Phase 3 | Completed | Maruho Co., Ltd. | 751 | 2013-08-01 | 2018-11-27 |
| Phase III Study of ASP2151 in Herpes Simplex Patients ASP2151, ASP2151 placebo - Herpes Simplex | Phase 3 | Completed | Maruho Co., Ltd. | 468 | 2013-08-01 | 2024-10-09 |
| Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers ASP2151, Valacyclovir, Placebo - Safety of ASP2151 | Phase 1 | Terminated | Astellas Pharma Inc | 442 | 2009-03-01 | 2013-02-28 |
| Dose-finding Study of ASP2151 in Subjects With Herpes Zoster ASP2151, Valacyclovir hydrochloride - Herpes Zoster | Phase 2 | Completed | Astellas Pharma Inc | 403 | 2007-11-13 | 2018-11-23 |
| A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes ASP2151, valacyclovir, Placebo - Herpes Genitalis | Phase 2 | Completed | Astellas Pharma Inc | 695 | 2007-06-21 | 2017-12-07 |
| Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly Subjects ASP2151, Placebo - Healthy Subjects | Phase 1 | Completed | Astellas Pharma Inc | 36 | 2006-07-01 | 2016-08-29 |
| Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food ASP2151, Placebo - Herpes Genitalis, Herpes Zoster | Phase 1 | Completed | Astellas Pharma Europe Ltd. | 72 | 2005-09-01 | 2016-08-02 |
Herpes Simplex (7) · Herpes Zoster (3) · Herpes Genitalis (2) · Sexually Transmitted Diseases (1)
Maruho Europe Limited (5) · Astellas Pharma Inc (4) · Maruho Co., Ltd. (3) · Astellas Pharma Europe Ltd. (1)
Japan (5) · United Kingdom (5) · United States (2) · France (1)
Joachim Dr Kempeni (1) · Maruho Co.,Ltd. Kyoto R&D Center (1)
2005 (1), 2014 (1)